Details

Autor(en) / Beteiligte

• Ammous-Boukhris, Nihel
• Mosbah, Amor
• Ayadi, Wajdi
• Sahli, Emna
• Chevance, Soizic
• Bondon, Arnaud
• Gargouri, Ali
• Baudy-Floc'h, Michele
• Mokdad-Gargouri, Raja

Titel

B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1

Ist Teil von

• Scientific reports, 2019-03, Vol.9 (1), p.4389-4389, Article 4389

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2019

Quelle

MEDLINE

Beschreibungen/Notizen

• Latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus (EBV) plays an important role in EBV-induced cell transformation. Down-regulation of the LMP1 expression had shown promising results on cancer cell therapy. In this study, we identified by Phage display a novel peptide called B1.12 (ACPLDLRSPCG) which selectively binds to the extracellular loop (B1) of the LMP1 oncoprotein as demonstrated by molecular docking, NMR and ITC. Using an LMP1 expressing cell line, we showed that B1.12 decreased cell viability, and induced G0/G1 cell cycle arrest. In addition, the expression of A20, pAkt, and pNFkb (pRelA536) in C666-1 cells treated with B1.12 decreased compared to the untreated cells. In conclusion, we selected a novel peptide able to bind specifically to the extracellular loop of LMP1 and thus modulate its oncogenic properties.